
QIAGEN N.V. QGEN
Annual report 2025
added 04-18-2026
QIAGEN N.V. EV - Enterprise Value 2011-2026 | QGEN
Annual EV - Enterprise Value QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 11.3 B | 13.9 B | 10.2 B | 10.7 B | 9.53 B | 7.7 B | 6.63 B | 6.73 B | 6.23 B | 5.95 B | 4.8 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.9 B | 4.8 B | 8.52 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 17.26 | -7.0 % | $ 181 M | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.34 | -17.79 % | $ 1.78 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.78 | -2.53 % | $ 477 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 112.09 | -1.02 % | $ 34.1 B | ||
|
Castle Biosciences
CSTL
|
463 M | $ 19.05 | 0.9 % | $ 552 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
15.3 B | $ 139.97 | -2.28 % | $ 22.3 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 19.83 | -3.22 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 94.74 | -2.0 % | $ 6.39 B | ||
|
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 419.82 | 0.16 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 043.89 | 0.19 % | $ 21.5 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 3.6 | -0.69 % | $ 333 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.28 | -0.96 % | $ 1.06 B | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
432 M | $ 18.46 | -2.48 % | $ 413 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 157.18 | -1.33 % | $ 7.79 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Natera
NTRA
|
5.53 B | $ 186.22 | -5.43 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 25.27 | -0.94 % | $ 24 B | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
15.2 B | $ 92.95 | -5.79 % | $ 11.7 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 5.73 | -1.55 % | $ 239 M | ||
|
Personalis
PSNL
|
380 M | $ 6.47 | -3.64 % | $ 577 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 117.95 | 0.73 % | $ 9.73 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.99 | -0.01 % | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 49.3 | -6.89 % | $ 2.95 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.31 | -4.04 % | $ 5.31 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 251.18 | -1.12 % | $ 20.9 B | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 439.31 | -1.97 % | $ 166 B | ||
|
Trinity Biotech plc
TRIB
|
327 M | $ 0.57 | -1.49 % | $ 205 M | ||
|
Celcuity
CELC
|
5.57 B | $ 134.9 | 0.13 % | $ 6.31 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
21.6 B | $ 331.34 | -0.56 % | $ 19.7 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 8.27 | -1.9 % | $ 1.79 B |